Regenxbio and NS Pharma evaluate additional RGX-121 data
Regenxbio and NS Pharma are evaluating additional data for RGX-121, according to the market alert, with no catalyst or magnitude supplied.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.